MarginsXMarginsX
Home › Markets › Health Care › NCNA

NuCana plc American Depositary Share (NCNA)

NCNA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.8631
-7.46% on the day
Market cap
$4.4M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerNCNA on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited Kingdom
IPO year2017
SEC CIK0001709626
SEC industry codePharmaceutical Preparations
Incorporated inUnited Kingdom

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
39.0 months
24.3M GBP cash at December 31, 2025
Share count, 1 year
+14551.0%
2024-12-31 to 2025-12-31 · +39634.0% over 3 years
Going-concern doubt
No
20-F filed March 19, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"If there is substantial doubt about our ability to continue as a going concern in the future, it may negatively impact the trading price of our securities, have an adverse impact on our relationship with third parties with whom we do business, including our customers, vendors and employees, and could make it challenging and difficult for us to raise additional equity or debt financing to the extent needed, all of whi"
20-F 2026-03-19
Cash and burn24.3M GBP cash; operating cash flow -1.9M GBP a quarter.Report 2025-12-31
Shares outstanding4,161,971 (2025-12-31); 28,407 a year earlier; 10,475 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Edinburgh, United KingdomPCAOB Form AP 2026-04-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
Not filed-29.4M GBP-7.5M GBP24.3M GBPNo debt tagsNeeds four quarters20-F 2026-03-19
FY 2024
2024-12-31
Not filed-19.0M GBP-19.1M GBP6.7M GBPNo debt tagsNeeds four quarters20-F 2026-03-19
FY 2023
2023-12-31
Not filed-27.6M GBP-26.4M GBP17.2M GBPNo debt tagsNeeds four quarters20-F 2026-03-19
FY 2022
2022-12-31
Not filed-32.0M GBP-23.2M GBP41.9M GBPNo debt tagsNeeds four quarters20-F 2025-03-20
FY 2021
2021-12-31
Not filed-40.5M GBP-23.8M GBP60.3M GBPNo debt tagsNeeds four quarters20-F 2024-03-20
FY 2020
2020-12-31
Not filed-30.7M GBP-21.6M GBP87.4M GBPNo debt tagsNeeds four quarters20-F 2023-04-04
FY 2019
2019-12-31
Not filed-21.4M GBP-23.8M GBP52.0M GBPNo debt tagsNeeds four quarters20-F 2022-04-27
FY 2018
2018-12-31
Not filed-13.8M GBP-12.2M GBP77.0M GBPNo debt tagsNeeds four quarters20-F 2021-03-04

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in GBP.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-06-27
Latest annual report20-F2026-03-19
Latest quarterly / interim6-K2026-11-12

Source: SEC EDGAR submissions feed, 283 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-0.5%
1 month-11.1%
3 months-37.0%
Year to date-74.1%
1 year-73.3%
From 52-week high-78.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
KPRXKiora Pharmaceuticals Inc.$0.9820-20.16%$4.3M
BGMSBio Green Med Solution Inc.$0.6502+1.55%$4.3M
SKYESkye Bioscience Inc.$1.06-2.29%$4.7M
CANFCan-Fite Biopharma Ltd$1.56+9.86%$4.7M
PCSAProcessa Pharmaceuticals Inc.$1.72-7.53%$4.8M
PULMPulmatrix Inc.$1.33+2.31%$4.9M
SCNXScienture Holdings Inc.$2.99+3.10%$4.9M
TRAWTraws Pharma Inc.$0.2600+3.59%$4.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier